Log In
Print this Print this

Sevikar HCT, Tribenzor, olmesartan/amlodipine/hydrochlorothiazide (CS-8635)

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionFixed-dose combination of olmesartan, an angiotensin II receptor blocker, amlodipine, a dihydropyridine calcium channel blocker, and hydrochlorothiazide, a diuretic
Molecular Target Calcium channel
Mechanism of ActionCalcium channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today